3. Galic, S, Oakhill, JS & Steinberg, GR (2010) Adipose tissue as an endocrine organ. Mol Cell Endocrinol 316, 129–139.
4. Noeman, SA, Hamooda, HE & Baalash, AA (2011) Biochemical study of oxidative stress markers in the liver, kidney and heart of high fat diet induced obesity in rats. Diabetol Metab Syndr 3, 17.
5. Knight, JA (2011) Diseases and disorders associated with excess body weight. Ann Clin Lab Sci 41, 107–121.
6. Convit, A (2012) Obesity is associated with structural and functional brain abnormalities: where do we go from here? Psychosom Med 74, 673–674.
7. Shefer, G, Marcus, Y & Stern, N (2013) Is obesity a brain disease? Neurosci Biobehav Rev 37, 2489–2503.
8. Coelho, M, Oliveira, T & Fernandes, R (2013) Biochemistry of adipose tissue: an endocrine organ. Arch Med Sci 9, 191–200.
9. Kleinridders, A, Könner, AC & Brüning, JC (2009) CNS – targets in control of energy and glucose homeostasis. Curr Opin Pharmacol 9, 794–804.
10. Johnson, AR, Milner, JJ & Makowski, L (2012) The inflammation highway: metabolism accelerates inflammatory traffic in obesity. Immunol Rev 249, 218–238.
11. Muñoz, A & Costa, M (2013) Nutritionally mediated oxidative stress and inflammation. Oxid Med Cell Longev 2013, 610950.
12. Wall, R, Ross, RP, Fitzgerald, GF, et al. (2010) Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. Nutr Rev 68, 280–289.
13. Ellulu, MS, Khaza’ai, H, Abed, Y, et al. (2015) Role of fish oil in human health and possible mechanism to reduce the inflammation. Inflammopharmacology 23, 79–89.
14. Gomez-Pinilla, F (2008) Brain foods: the effects of nutrients on brain function. Nat Rev Neurosci 9, 568–578.
15. Buckley, JD & Howe, PR (2010) Long-chain omega-3 polyunsaturated fatty acids may be beneficial for reducing obesity-a review. Nutrients 2, 1212–1230.
16. Golub, N, Geba, D, Mousa, SA, et al. (2011) Greasing the wheels of managing overweight and obesity with omega-3 fatty acids. Med Hypotheses 77, 1114–1120.
17. Campbell, SC & Bello, NT (2012) Omega-3 fatty acids and obesity. J Food Nutr Disor 1, 1–2.
18. Mori, T, Kondo, H, Hase, T, et al. (2007) Dietary fish oil upregulates intestinal lipid metabolism and reduces body weight gain in C57BL/6J mice. J Nutr 137, 2629–2634.
19. Moritz, B, Wazlawik, E, Minatti, J, et al. (2008) Interferência dos ácidos graxos ômega-3 nos lipídeos sangüíneos de ratos submetidos ao exercício de natação (Omega-3 fatty acids interference on the blood lipids of rats subjected to swimming exercise). Rev Nutr 21, 659–669.
20. Rokling-Andersen, MH, Rustan, AC, Wensaas, AJ, et al. (2009) Marine n-3 fatty acids promote size reduction of visceral adipose depots, without altering body weight and composition, in male Wistar rats fed a high-fat diet. Br J Nutr 102, 995–1006.
21. Samane, S, Christon, R, Dombrowski, L, et al. (2009) Fish oil and argan oil intake differently modulate insulin resistance and glucose intolerance in a rat model of dietary-induced obesity. Metabolism 58, 909–919.
22. Kalupahana, NS, Claycombe, K, Newman, SJ, et al. (2010) Eicosapentaenoic acid prevents and reverses insulin resistance in high-fat diet-induced obese mice via modulation of adipose tissue inflammation. J Nutr 140, 1915–1922.
23. Cintra, DE, Ropelle, ER, Moraes, JC, et al. (2012) Unsaturated fatty acids revert diet-induced hypothalamic inflammation in obesity. PLOS ONE 7, e30571.
24. Liu, X, Xue, Y, Liu, C, et al. (2013) Eicosapentaenoic acid-enriched phospholipid ameliorates insulin resistance and lipid metabolism in diet-induced-obese mice. Lipids Health Dis 12, 109.
25. Ávila, PR, Marques, SO, Luciano, TF, et al. (2013) Resveratrol and fish oil reduce catecholamine-induced mortality in obese rats: role of oxidative stress in the myocardium and aorta. Br J Nutr 110, 1580–1590.
26. Pimentel, GD, Lira, FS, Rosa, JC, et al. (2013) High-fat fish oil diet prevents hypothalamic inflammatory profile in rats. ISRN Inflamm 2013, 419823.
27. Rossmeisl, M, Medrikova, D, van Schothorst, EM, et al. (2014) Omega-3 phospholipids from fish suppress hepatic steatosis by integrated inhibition of biosynthetic pathways in dietary obese mice. Biochim Biophys Acta 1841, 267–278.
28. Bargut, TC, Mandarim-de-Lacerda, CA & Aguila, MB (2015) A high-fish-oil diet prevents adiposity and modulates white adipose tissue inflammation pathway in mice. J Nutr Biochem 26, 960–969.
29. Philp, LK, Heilbronn, LK, Janovska, A, et al. (2015) Dietary enrichment with fish oil prevents high fat-induced metabolic dysfunction in skeletal muscle in mice. PLOS ONE 10, e0117494.
30. Yook, JS, Kim, KA, Park, JE, et al. (2015) Microalgal oil supplementation has an anti-obesity effect in C57BL/6J mice fed a high fat diet. Prev Nutr Food Sci 20, 230–237.
31. Abdel-Maksoud, SM, Hassanein, SI, Gohar, NA, et al. (2016) Investigation of brain-derived neurotrophic factor (BDNF) gene expression in hypothalamus of obese rats: modulation by omega-3 fatty acids. Nutr Neurosci 1, 6.
32. Cavaliere, G, Trinchese, G, Bergamo, P, et al. (2016) Polyunsaturated fatty acids attenuate diet induced obesity and insulin resistance, modulating mitochondrial respiratory uncoupling in rat skeletal muscle. PLOS ONE 11, e0149033.
33. Viggiano, E, Mollica, MP, Lionetti, L, et al. (2016) Effects of an high-fat diet enriched in lard or in fish oil on the hypothalamic Amp-activated protein kinase and inflammatory mediators. Front Cell Neurosci 10, 150.
34. de Sá, RD, Crisma, AR, Cruz, MM, et al. (2016) Fish oil prevents changes induced by a high-fat diet on metabolism and adipokine secretion in mice subcutaneous and visceral adipocytes. J Physiol 594, 6301–6317.
35. Go, RE, Hwang, KA, Park, GT, et al. (2016) Effects of microalgal polyunsaturated fatty acid oil on body weight and lipid accumulation in the liver of C57BL/6 mice fed a high fat diet. J Biomed Res 30, 234–242.
36. Bargut, TCL, Santos, LP, Machado, DGL, et al. (2017) Eicosapentaenoic acid (EPA) v. Docosahexaenoic acid (DHA): effects in epididymal white adipose tissue of mice fed a high-fructose diet. Prostaglandins Leukot Essent Fatty Acids 123, 14–24.
37. DeFina, LF, Marcoux, LG, Devers, SM, et al. (2011) Effects of omega-3 supplementation in combination with diet and exercise on weight loss and body composition. Am J Clin Nutr 93, 455–462.
38. Itariu, BK, Zeyda, M, Hochbrugger, EE, et al. (2012) Long-chain n-3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial. Am J Clin Nutr 96, 1137–1149.
39. Crochemore, IC, Souza, AF, de Souza, AC, et al. (2012)
ω-3 Polyunsaturated fatty acid supplementation does not influence body composition, insulin resistance, and lipemia in women with type 2 diabetes and obesity. Nutr Clin Pract 27, 553–560.
40. Kiecolt-Glaser, JK, Belury, MA, Andridge, R, et al. (2012) Omega-3 supplementation lowers inflammation in healthy middle-aged and older adults: a randomized controlled trial. Brain Behav Immun 26, 988–995.
41. Kiecolt-Glaser, JK, Epel, ES, Belury, MA, et al. (2013) Omega-3 fatty acids, oxidative stress, and leukocyte telomere length: a randomized controlled trial. Brain Behav Immun 28, 16–24.
42. Munro, IA & Garg, ML (2012) Dietary supplementation with n-3 PUFA does not promote weight loss when combined with a very-low-energy diet. Br J Nutr 108, 1466–1474.
43. Munro, IA & Garg, ML (2013) Dietary supplementation with long chain omega-3 polyunsaturated fatty acids and weight loss in obese adults. Obes Res Clin Pract 7, e173–e181.
44. Munro, IA & Garg, ML (2013) Prior supplementation with long chain omega-3 polyunsaturated fatty acids promotes weight loss in obese adults: a double-blinded randomised controlled trial. Food Funct 4, 650–658.
45. Juárez-López, C, Klünder-Klünder, M, Madrigal-Azcárate, A, et al. (2013) Omega-3 polyunsaturated fatty acids reduce insulin resistance and triglycerides in obese children and adolescents. Pediatr Diabetes 14, 377–383.
46. Ellulu, MS, Khaza’ai, H, Patimah, I, et al. (2016) Effect of long chain omega-3 polyunsaturated fatty acids on inflammation and metabolic markers in hypertensive and/or diabetic obese adults: a randomized controlled trial. Food Nutr Res 60, 29268.
47. Wang, F, Wang, Y, Zhu, Y, et al. (2017) Treatment for 6 months with fish oil-derived n-3 polyunsaturated fatty acids has neutral effects on glycemic control but improves dyslipidemia in type 2 diabetic patients with abdominal obesity: a randomized, double-blind, placebo-controlled trial. Eur J Nutr 56, 2415–2422.
48. Huerta, AE, Navas-Carretero, S, Prieto-Hontoria, PL, et al. (2015) Effects of α-lipoic acid and eicosapentaenoic acid in overweight and obese women during weight loss. Obesity (Silver Spring) 23, 313–321.
49. Huerta, AE, Prieto-Hontoria, PL, Sáinz, N, et al. (2016) Supplementation with α-lipoic acid alone or in combination with eicosapentaenoic acid modulates the inflammatory status of healthy overweight or obese women consuming an energy-restricted diet. J Nutr 146, 889S–896S.
50. Huerta, AE, Prieto-Hontoria, PL, Fernández-Galilea, M, et al. (2017) Effects of dietary supplementation with EPA and/or α-lipoic acid on adipose tissue transcriptomic profile of healthy overweight/obese women following a hypocaloric diet. Biofactors 43, 117–131.
51. Allaire, J, Couture, P, Leclerc, M, et al. (2016) A randomized, crossover, head-to-head comparison of eicosapentaenoic acid and docosahexaenoic acid supplementation to reduce inflammation markers in men and women: the Comparing EPA to DHA (ComparED) Study. Am J Clin Nutr 104, 280–287.
52. Allaire, J, Harris, WS, Vors, C, et al. (2017) Supplementation with high-dose docosahexaenoic acid increases the Omega-3 Index more than high-dose eicosapentaenoic acid. Prostaglandins Leukot Essent Fatty Acids 120, 8–14.
53. Vors, C, Allaire, J, Marin, J, et al. (2017) Inflammatory gene expression in whole blood cells after EPA v. DHA supplementation: Results from the ComparED study. Atherosclerosis 257, 116–122.
54. Bhaskaran, K, Douglas, I, Forbes, H, et al. (2014) Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults. Lancet 384, 755–765.
55. Halberg, N, Wernstedt-Asterholm, I & Scherer, PE (2008) The adipocyte as an endocrine cell. Endocrinol Metab Clin North Am 37, 753–768.
56. Ouchi, N, Parker, JL, Lugus, JJ, et al. (2011) Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11, 85–97.
57. Exley, MA, Hand, L, O’Shea, D, et al. (2014) Interplay between the immune system and adipose tissue in obesity. J Endocrinol 223, R41–R48.
58. Maury, E & Brichard, SM (2010) Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol 314, 1–16.
59. Mathis, D (2013) Immunological goings-on in visceral adipose tissue. Cell Metab 17, 851–859.
60. Donath, MY & Shoelson, SE (2011) Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11, 98–107.
61. Moore, KJ & Tabas, I (2011) Macrophages in the pathogenesis of atherosclerosis. Cell 145, 341–355.
62. Cai, D (2013) Neuroinflammation and neurodegeneration in overnutrition-induced diseases. Trends Endocrinol Metab 24, 40–47.
63. Thaler, JP, Yi, CX, Schur, EA, et al. (2012) Obesity is associated with hypothalamic injury in rodents and humans. J Clin Invest 122, 153–162.
64. Freeman, LR, Zhang, L, Nair, A, et al. (2013) Obesity increases cerebrocortical reactive oxygen species and impairs brain function. Free Radic Biol Med 56, 226–233.
65. Milanski, M, Degasperi, G, Coope, A, et al. (2009) Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity. J Neurosci 29, 359–370.
66. Moraes, JC, Coope, A, Morari, J, et al. (2009) High-fat diet induces apoptosis of hypothalamic neurons. PLoS ONE 4, e5045.
67. Boitard, C, Cavaroc, A, Sauvant, J, et al. (2014) Impairment of hippocampal-dependent memory induced by juvenile high-fat diet intake is associated with enhanced hippocampal inflammation in rats. Brain Behav Immun 40, 9–17.
68. Nummenmaa, L, Hirvonen, J, Hannukainen, JC, et al. (2012) Dorsal striatum and its limbic connectivity mediate abnormal anticipatory reward processing in obesity. PLOS ONE 7, e31089.
69. Velloso, LA & Schwartz, MW (2011) Altered hypothalamic function in diet induced obesity. Int J Obes (Lond) 35, 1455–1465.
70. Williams, LM (2012) Hypothalamic dysfunction in obesity. Proc Nutr Soc 71, 521–533.
71. Karatsoreos, IN, Thaler, JP, Borgland, SL, et al. (2013) Food for thought: hormonal, experiential, and neural influences on feeding and obesity. J Neurosci 33, 17610–17616.
72. Drougard, A, Fournel, A, Valet, P, et al. (2015) Impact of hypothalamic reactive oxygen species in the regulation of energy metabolism and food intake. Front Neurosci 9, 1–12.
73. Kälin, S, Heppner, FL, Bechmann, I, et al. (2015) Hypothalamic innate immune reaction in obesity. Nat Rev Endocrinol 11, 339–351.
74. Thaler, JP, Choi, SJ, Schwartz, MW, et al. (2010) Hypothalamic inflammation and energy homeostasis: resolving the paradox. Front Neuroendocrinol 31, 79–84.
75. Patel, PS, Buras, E & Balasubramanyam, A (2013) The role of the immune system in obesity and insulin resistance. J Obes 2013, 616193.
76. Gregor, MF & Hotamisligil, GS (2011) Inflammatory mechanisms in obesity. Annu Rev Immunol 29, 415–445.
77. Kanoski, E & Davidson, TL (2011) Western diet consumption and cognitive impairment: links to hippocampal dysfunction and obesity. Physiol Behav 103, 59–58.
78. Davidson, TL, Hargrave, SL, Swithers, SE, et al. (2013) Inter-relationships among diet, obesity and hippocampal-dependent cognitive function. Neuroscience 253, 110–122.
79. Miller, AA & Spencer, SJ (2014) Obesity and neuroinflammation: a pathway to cognitive impairment. Brain Behav Immun 42, 10–21.
80. Park, HR, Park, M, Choi, J, et al. (2010) A high-fat diet impairs neurogenesis: involvement of lipid peroxidation and brain-derived neurotrophic factor. Neurosci Lett 482, 235–239.
81. Moroz, N, Tong, M, Longato, L, et al. (2008) Limited Alzheimer-type neurodegeneration in experimental obesity and type 2 diabetes mellitus. J Alzheimers Dis 15, 29–44.
82. Jeon, BT, Jeong, EA, Shin, HJ, et al. (2012) Resveratrol attenuates obesity-associated peripheral and central inflammation and improves memory deficit in mice fed a high-fat diet. Diabetes 61, 1444–1454.
83. Tomasi, D & Volkow, ND (2013) Striatocortical pathway dysfunction in addiction and obesity: differences and similarities. Crit Rev Biochem Mol Biol 48, 1–19.
84. Farr, OM, Li, CS & Mantzoros, CS (2016) Central nervous system regulation of eating: insights from human brain imaging. Metabolism 65, 699–713.
85. Geiger, BM, Behr, GG, Frank, LE, et al. (2008) Evidence for defective mesolimbic dopamine exocytosis in obesity-prone rats. FASEB J 22, 2740–2746.
86. Mathes, WF, Nehrenberg, DL, Gordon, R, et al. (2010) Dopaminergic dysregulation in mice selectively bred for excessive exercise or obesity. Behav Brain Res 210, 155–163.
87. Stice, E, Spoor, S, Bohon, C, et al. (2008) Relation of reward from food intake and anticipated food intake to obesity: a functional magnetic resonance imaging study. J Abnorm Psychol 117, 924–935.
88. Stice, E, Yokum, S, Blum, K, et al. (2010) Weight gain is associated with reduced striatal response to palatable food. J Neurosci 30, 13105–13109.
89. Pucci, A & Finer, N (2015) New medications for treatment of obesity: metabolic and cardiovascular effects. Can J Cardiol 31, 142–152.
90. Flachs, P, Ruhl, R, Hensler, M, et al. (2011) Synergistic induction of lipid catabolism and anti-inflammatory lipids in white fat of dietary obese mice in response to calorie restriction and n-3 fatty acids. Diabetologia 54, 2626–2638.
91. Hensler, M, Bardova, K, Jilkova, ZM, et al. (2011) The inhibition of fat cell proliferation by n-3 fatty acids in dietary obese mice. Lipids Health Dis 10, 128.
92. Surette, ME (2008) The science behind dietary omega-3 fatty acids. CMAJ 178, 177–180.
93. Gómez Candela, C, Bermejo López, LM & Loria Kohen, V (2011) Importance of a balanced omega 6/omega 3 ratio for the maintenance of health: nutritional recommendations. Nutr Hosp 26, 323–329.
94. Arbex, AK, Bizarro, VR, Santos, JCS, et al. (2015) The impact of the essential fatty acids (EFA) in human health. OJEMD 5, 98–104.
95. Anderson, BM & Ma, DW (2009) Are all n-3 polyunsaturated fatty acids created equal? Lipids Health Dis 8, 33.
96. Simopoulos, AP (2008) The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood) 233, 674–688.
97. Barceló-Coblijn, G & Murphy, EJ (2009) Alpha-linolenic acid and its conversion to longer chain n-3 fatty acids: benefits for human health and a role in maintaining tissue n-3 fatty acid levels. Prog Lipid Res 48, 355–374.
98. Brenna, JT, Salem, N Jr, Sinclair, AJ, et al. (2009) Alpha-linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot Essent Fatty Acids 80, 85–91.
99. Calder, PC (2012) Mechanisms of action of (n-3) fatty acids. J Nutr 142, 592S–599S.
100. Agrawal, R & Gomez-Pinilla, F (2012) ‘Metabolic syndrome’ in the brain: deficiency in omega-3 fatty acid exacerbates dysfunctions in insulin receptor signalling and cognition. J Physiol 590, 2485–2499.
101. Farooqui, AA (2012)
n-3 fatty acid-derived lipid mediators in the brain: new weapons against oxidative stress and inflammation. Curr Med Chem 19, 532–543.
102. Sun, GY, Simonyi, A, Fritsche, KL, et al. (2017) Docosahexaenoic acid (DHA): an essential nutrient and a nutraceutical for brain health and diseases. Prostaglandins Leukot Essent Fatty Acids (epublication ahead of print version 10 March 2017).
103. Lauritzen, L, Brambilla, P, Mazzocchi, A, et al. (2016) DHA effects in brain development and function. Nutrients 8, 1–17.
104. Chapkin, RS, Kim, W, Lupton, JR, et al. (2009) Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation. Prostaglandins Leukot Essent Fatty Acids 81, 187–191.
105. Yates, CM, Calder, PC & Ed Rainger, G (2014) Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease. Pharmacol Ther 141, 272–282.
106. Lorente-Cebrián, S, Costa, AG, Navas-Carretero, S, et al. (2015) An update on the role of omega-3 fatty acids on inflammatory and degenerative diseases. J Physiol Biochem 71, 341–349.
107. Flock, MR, Rogers, CJ, Prabhu, KS, et al. (2013) Immunometabolic role of long-chain omega-3 fatty acids in obesity-induced inflammation. Diabetes Metab Res Rev 29, 431–445.
108. Martínez-Fernández, L, Laiglesia, LM, Huerta, AE, et al. (2015) Omega-3 fatty acids and adipose tissue function in obesity and metabolic syndrome. Prostaglandins Other Lipid Mediat 121, 24–41.
109. Lee, JH, O’Keefe, JH, Lavie, CJ, et al. (2008) Omega-3 fatty acids for cardioprotection. Mayo Clin Proc 83, 324–332.
110. Bermúdez Menéndez de la Granda, M & Sinclair, AJ (2009) Fatty acids and obesity. Curr Pharm Des 15, 4117–4125.
111. Trépanier, MO, Hopperton, KE, Orr, SK, et al. (2016)
n-3 Polyunsaturated fatty acids in animal models with neuroinflammation: an update. Eur J Pharmacol 785, 187–206.
112. Flachs, P, Rossmeisl, M, Bryhn, M, et al. (2009) Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism. Clin Sci 116, 1–16.
113. Lorente-Cebrián, S, Costa, AG, Navas-Carretero, S, et al. (2013) Role of omega-3 fatty acids in obesity, metabolic syndrome, and cardiovascular diseases: a review of the evidence. J Physiol Biochem 69, 633–651.
114. Bender, N, Portmann, M, Heg, Z, et al. (2014) Fish or n3-PUFA intake and body composition: a systematic review and meta-analysis. Obes Rev 15, 657–665.
115. Du, S, Jin, J, Fang, W, et al. (2015) Does fish oil have an anti-obesity effect in overweight/obese adults? A meta-analysis of randomized controlled trials. PLOS ONE 10, e0142652.
116. Zhang, YY, Liu, W, Zhao, TY, et al. (2017) Efficacy of omega-3 polyunsaturated fatty acids supplementation in managing overweight and obesity: a meta-analysis of randomized clinical trials. J Nutr Health Aging 21, 187–192.
117. Bashir, S, Sharma, Y, Elahi, A, et al. (2016) Amelioration of obesity-associated inflammation and insulin resistance in c57bl/6 mice via macrophage polarization by fish oil supplementation. J Nutr Biochem 33, 82–90.
118. Inoue, T, Tanaka, M, Masuda, S, et al. (2017) Omega-3 polyunsaturated fatty acids suppress the inflammatory responses of lipopolysaccharide-stimulated mouse microglia by activating SIRT1 pathways. Biochim Biophys Acta 1862, 552–560.
119. González-Périz, A, Horrillo, R, Ferré, N, et al. (2009) Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. FASEB J 23, 1946–1957.
120. Neuhofer, A, Zeyda, M, Mascher, D, et al. (2013) Impaired local production of proresolving lipid mediators in obesity and 17-HDHA as a potential treatment for obesity-associated inflammation. Diabetes 62, 1945–1956.
121. Huang, CW, Chien, YS, Chen, YJ, et al. (2016) Role of n-3 polyunsaturated fatty acids in ameliorating the obesity-induced metabolic syndrome in animal models and humans. Int J Mol Sci 17, E1689.
122. Shang, T, Liu, L, Zhou, J, et al. (2017) Protective effects of various ratios of DHA/EPA supplementation on high-fat diet-induced liver damage in mice. Lipids Health Dis 16, 65.
123. Tang, X, Li, ZJ, Xu, J, et al. (2012) Short term effects of different omega-3 fatty acid formulation on lipid metabolism in mice fed high or low fat diet. Lipids Health Dis 11, 70.
124. Rossmeisl, M, Jilkova, ZM, Kuda, O, et al. (2012) Metabolic effects of n-3 PUFA as phospholipids are superior to triglycerides in mice fed a high-fat diet: possible role of endocannabinoids. PLOS ONE 7, e38834.
125. Simopoulos, AP (2016) An increase in the omega-6/omega-3 fatty acid ratio increases the risk for obesity. Nutrients 8, 128.